Yurou Zheng

Yurou Zheng is an equity analyst, Asia, for Morningstar*. She covers stocks in the healthcare sector for the Asia team. Her coverages include biotech or biopharmaceuticals, medical device companies, and service providers.

Before joining the equity research team in 2022, Zheng was in the Morningstar Fund Data team for a regulation-driven project in the Australian market. Prior to Morningstar, she worked in a start-up venture capital fund covering the healthcare sector and worked at PwC Deals in Italy.

Zheng holds a bachelor’s degree in International Economics and Finance from Bocconi University. She also passed the examination for the Fund Practitioner Qualification by the Asset Management Association of China (AMAC) in 2021.

* Morningstar Investment Adviser Singapore Pte. Ltd. (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc